Esteve

Esteve is a nearly century-old Spanish pharmaceutical company that has evolved into an international specialty pharma and CDMO player. The company maintains a dual-strategy model, developing and commercializing its own pharmaceutical products while also offering high-value contract manufacturing services for small-molecule active pharmaceutical ingredients (APIs). Recent strategic moves include expanding its U.S. commercial presence through acquisition, significant investment in CDMO capacity in both Europe and North America, and achieving B Corp certification, underscoring its commitment to social and environmental responsibility. This positions Esteve as a purpose-driven organization balancing commercial growth with sustainable impact.

Small molecule API synthesis & manufacturing (CDMO); RNA & Gene Therapy capabilities (Pharma R&D).

In CDMO services, competes with large global players (Lonza, Catalent) and specialized API manufacturers on technology, quality, and cost. In proprietary pharma, competes with other specialty pharma companies in targeted therapeutic areas, where commercial execution and portfolio selection are key.